This study is looking at whether using a special electronic pillbox and text messages can help young people (ages 13-25) who have had a kidney or liver transplant remember to take their tacrolimus or sirolimus medication. Many young transplant patients struggle to take their anti-rejection medicines regularly, which can lead to serious problems like organ rejection. This study aims to see if this technology can improve how well patients take their medication. Success will be measured by how consistently participants take their doses over 16 months. The current recruitment status is unclear.

Study design

This interventional study plans to enroll 65 participants. It uses a behavioral intervention where participants receive an electronic pillbox.

What's involved

You would use an electronic pillbox for your prescribed medicines for up to 16 months. The research team will teach you how to use this device.

Compensation

Not stated in the trial record.

Follow-up

Your medication adherence will be measured at 16 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.